Skip to main content
. Author manuscript; available in PMC: 2020 Jul 27.
Published in final edited form as: Nat Microbiol. 2020 Jan 27;5(3):511–524. doi: 10.1038/s41564-019-0649-5

Extended Data Fig. 4. F. PB1 administration alters microbiota and its metabolic profile.

Extended Data Fig. 4

a, LEfSe comparison results between the microbiota of Vehicle and F. PB1 treated mice at 12 weeks with the highest linear discriminant analysis LDA score (log10 ≥ 2.0); Veh, n = 8; F. PB1 n = 14 mice/group. b, Fecal concentrations of succinate, isovalerate and valerate in WT and ApcMin/+ mice treated with vehicle (Veh) or F. PB1 as detected by UPLC-MS; WT Veh, WT F. PB1 n = 6; ApcMin/+ Veh n = 11; ApcMin/+ F. PB1 n = 10 mice/group. Data from two independent experiments and represented as means ± s.e.m.. P values were determined by two-way ANOVA with Bonferroni post-test.